NSE filing, NSE: VINEETLAB. Summary written from the filing by ALFA Finder's alert engine.
Vineet Laboratories Ltd: key numbers
- Share price
- ₹36.81
- Market cap
- ₹70.70 Cr
- Revenue (annual)
- ₹59.40 Cr
- Net profit (annual)
- ₹1.11 Cr
- P/E (TTM)
- 20.2×Sector 46.1×
- Promoter holding
- 5.98%+0.00% QoQ
- FII holding
- 0.24%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Vineet Laboratories Ltd
All →Vineet Laboratories Q1 FY27 Results: Turns Profitable, Net Profit ₹1.5 Cr
Vineet Laboratories Ltd reported revenue from operations of ₹10.4 Cr (+40.5% YoY) and net profit of ₹1.5 Cr for Q1 FY27.
- Key figure
- Net profit ₹1.5 Cr
Vineet Laboratories Board Meeting Date
Vineet Laboratories Limited has scheduled a board meeting on October 26, 2026, to consider and approve standalone financial results for the quarter ended June 30, 2026.
Vineet Laboratories Other Announcement
Vineet Laboratories Ltd has filed its quarterly shareholding pattern as per Regulation 31(1)(b) of SEBI (LODR) Regulations for the quarter ended September 30, 2026.
Vineet Laboratories Management Change
Mr. Vennapusa Premanand Reddy has resigned as a Director of Vineet Laboratories Limited, effective October 14, 2026.
Vineet Laboratories Management Change
Vineet Laboratories Limited announced the resignation of M/s. NSVR & Associates LLP as its statutory auditor, effective September 29, 2026. The company will appoint a successor.
Vineet Laboratories Other Announcement
Vineet Laboratories received an extension from the Registrar of Companies, Hyderabad, to hold its 10th Annual General Meeting by 30th November 2026.
Other other announcement announcements
All →NIIT Learning Systems Other Announcement
NIIT Learning Systems board recommended appointing Price Waterhouse Chartered Accountants LLP as statutory auditor for five years from the 25th AGM. The incumbent S. R. Batliboi firm completes its second term.
- Execution
- Five consecutive years, from the 25th AGM (2027) until the 30th AGM (2032)
Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals appointed Talati and Talati LLP as Statutory Auditor for a 60-month term, effective 29 October 2026. The appointment was approved at the board meeting held the same day.
- Execution
- 60 months
Magson Retail & Distribution Other Announcement
Magson Retail submitted its Regulation 76 Reconciliation of Share Capital Audit Report for the quarter ended 30 September 2026. The report shows a 9,15,940 share difference between issued and listed capital, pending exchange listing approval.
Ekennis Software Service Other Announcement
Ekennis Software declared Regulation 23 related party transaction rules non-applicable for H1 FY27, as its paid-up capital and net worth are below SME thresholds. A CA certificate confirms the figures.
Shri Gang Industries and Allied Products Other Announcement
Shri Gang Industries filed its quarterly shareholding pattern dated 23 October 2026. The filing notes pledges, a warrant conversion, and a deceased promoter's shares moved to a nominee.
P N Gadgil Jewellers Other Announcement
P N Gadgil Jewellers filed a Monitoring Agency Report on its QIP proceeds for the quarter ended 30 September 2026. The agency reports no deviation from the stated objects of the Rs 7,000 million issue.